EUVIMEDEUVIMED entdecken
KorrekturRandomisierte kontrollierte StudieOpen Access

Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”

Helicobacter · 2026-05 · 31 (3)

DOI: 10.1111/hel.70141 ↗

Kurz gefasst

Korrektur in der Zeitschrift Helicobacter, online erschienen am 16.05.2026. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”. Helicobacter, 31(3). https://doi.org/10.1111/hel.70141

Vancouver

Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”. Helicobacter. 2026;31(3). doi:10.1111/hel.70141

BibTeX
@article{euvimed2026,
  title = {Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”},
  journal = {Helicobacter},
  year = {2026},
  volume = {31},
  number = {3},
  doi = {10.1111/hel.70141}
}
Kostenlos starten →